Co-Diagnostics Shares Halted To The Upside, Stock Now Up 20.80%
Portfolio Pulse from Benzinga Newsdesk
Co-Diagnostics shares have been halted to the upside, with the stock experiencing a significant increase of 20.80%.
September 05, 2024 | 1:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Co-Diagnostics shares have been halted due to a significant upward movement, with the stock price increasing by 20.80%.
The stock price of Co-Diagnostics has surged by 20.80%, leading to a trading halt. This indicates strong positive momentum and investor interest, likely driving the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100